02.08.19

Glycemic Control Tied to Better Outcome of Anti-VEGF Therapy for Diabetic Macular Edema

Source: Reuters

11.13.18

AsclepiX Therapeutics Raises $5 Million to Advance Therapies in AMD and DME

Source: AsclepiX Therapeutics

10.03.18

Fluocinolone Acetonide Implant Effective for Refractory Diabetic Macular Edema

Source: Reuters

09.20.18

Oxurion Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687 for Treatment of DME

Source: Oxurion

09.18.18

Allergan Announces New Partnership With the International Diabetes Federation

Source: Allergan

09.17.18

Oxurion to Present Scientific Findings Supporting Therapeutic Potential of THR-317 and THR-687 at EURETINA

Source: Oxurion NV

05.31.18

Clearside Biomedical Announces Topline Results from Phase 2 Clinical Trial of DME Combination Drug

Source: Clearside Biomedical

05.25.18

ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149 for Treatment of DME

Source: ThromboGenics

05.02.18

Verseon Presents New Efficacy Results on Oral DME Drug Candidate at ARVO

Source: Verseon

04.27.18

ThromboGenics Initiates Phase 2 Clinical Study Evaluating Anti-PlGF in Combination With Anti-VEGF for Treatment of DME

Source: ThromboGenics

View more stories